SIGYN THERAPEUTICS, INC. Net Income (Loss) Available to Common Stockholders, Diluted
SIGYN THERAPEUTICS, INC. (SIGY) reported Net Income (Loss) Available to Common Stockholders, Diluted of -$355.99 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2018-11-14
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2018-09-30 was -$355.99K.
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2018-06-30 was -$307.28K.
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2018-03-31 was -$739.39K.
- SIGYN THERAPEUTICS, INC. net income (loss) available to common stockholders, diluted for the quarter ending 2017-09-30 was -$1.50M.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month |
|---|---|---|---|
| 2018-09-30 | -$355.99K 10-Q · filed 2018-11-14 | -$663.26K derived: sum of 2 quarters · filed 2018-11-14 | -$1.40M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$307.28K 10-Q · filed 2018-08-13 | -$1.05M 10-Q · filed 2018-08-13 | |
| 2018-03-31 | -$739.39K 10-Q · filed 2018-05-15 | ||
| 2017-09-30 | -$1.50M 10-Q · filed 2018-11-14 | -$2.47M derived: sum of 2 quarters · filed 2018-11-14 | -$3.08M 10-Q · filed 2018-11-14 |
| 2017-06-30 | -$967.49K 10-Q · filed 2018-08-13 | -$1.58M 10-Q · filed 2018-08-13 | |
| 2017-03-31 | -$613.89K 10-Q · filed 2018-05-15 |